OxyNov is proud to announce the European release of FreeO2 at ERS 2016 exhibition (4-7 september). According to the company “it is the most significant breakthrough in oxygen therapy since the invention of the oxygen flowmeter in the early years of the 20th century“.  FreeO2 is a unique therapeutic and monitoring device that automatically takes in charge the O2 flow rate titration and the weaning of the patient based on the oxygen saturation target as defined by the clinician. FreeO2 is the first step of a comprehensive portfolio aimed at the optimization of oxygen therapy, at each step of the patient care process from hospital to home.
Hear about today’s challenges in oxygen therapy by Dr Mathieu Simon, pulmonologist at Quebec Heart and Lung Institute (IUCPQ) in this short video:

Take the opportuity to meet and discuss with OxyNov team at stand C23. Full demo is available.

RELATED: OXY’NOV gets $1M in funding from SOVAR and angel investors